Formulations in situ de donneurs de monoxyde d'azote

Abstract : In situ forming injectable systems are liquids based of a polymer and a pharmaceutically acceptable organic solvent, to which drug is added. After subcutaneous injection, contact with aqueous body fluids triggers polymer precipitation as implant (ISI) or microparticles (ISM). This matrix degrades then slowly while releasing the drug. In this work, ISI and ISM made of a copolymer of lactic and glycolic acid were developed for sustained release of S-nitrosothiols (RSNO), prodrugs of nitric oxide. Influence of formulation type, solvent, drug hydrophobicity and environment (in vitro vs in vivo) on polymeric matrix solidification, degradation and on RSNO release was studied. In vivo experiments proved that formulation extend (until 42 h) RSNO effect on arterial pressure of rats. However, matrix life-span is higher than 1 month, thus need optimization in view of an application requiring a long lasting release. Evaluation of these formulations has begun in a model of cardiac infarction. First, the feasibility of a direct injection into the infarct area has been established. Second, first results seem to indicate that these implants loaded with RSNO could enhance heart perfusion. Finally, porosity of these systems increases during their degradation, allowing cell recruitment and colonization of resulting matrix. An in vitro study conducted on implants with porosity artificially increased showed adhesion and proliferation of muscular cells seeded onto the systems. As a result, in situ formulations are suitable drug delivery systems for S-nitrosothiols, and represent a potential therapeutic tool, in particular in the field of ischemic diseases
Document type :
Theses
Complete list of metadatas

Cited literature [226 references]  Display  Hide  Download

https://hal.univ-lorraine.fr/tel-01750119
Contributor : Thèses Ul <>
Submitted on : Thursday, March 29, 2018 - 12:38:23 PM
Last modification on : Tuesday, April 10, 2018 - 1:27:56 AM

File

DDOC_T_2013_0127_PARENT.pdf
Files produced by the author(s)

Identifiers

  • HAL Id : tel-01750119, version 1

Citation

Marianne Parent. Formulations in situ de donneurs de monoxyde d'azote. Médecine humaine et pathologie. Université de Lorraine, 2013. Français. ⟨NNT : 2013LORR0127⟩. ⟨tel-01750119⟩

Share

Metrics

Record views

46

Files downloads

54